Crossmark

Treatments of chronic fatigue syndrome and its debilitating comorbidities: a 12-year population-based study

Published Online: 2022-06-11

Published Print: 2022-12

Authors

Leong, Kam-Hang

Yip, Hei-Tung

Kuo, Chien-Feng

Tsai, Shin-Yi http://orcid.org/0000-0001-7978-778X
Funding

Funding for this research was provided by:

Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW109-TDU-B-212-114004)

MOST Clinical Trial Consortium for Stroke (MOST 109-2321-B-039-002)

China Medical University Hospital (DMR-109-231)

Tseng-Lien Lin Foundation, Taichung, Taiwan

Mackay Medical College (1082A03)

Department of Medical Research at Mackay Memorial Hospital (MMH-107-135, MMH-109-79, MMH-109-103)
License Information

Text and Data Mining valid from 2022-06-11

Version of Record valid from 2022-06-11
More Information

Article History

Received: 25 March 2022

Accepted: 25 May 2022

First Online: 11 June 2022

Declarations

:

: The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. This study was approved by the Research Ethics Committee of the China Medical University Hospital (CMUH-104-REC2-115) and the Institutional Review Board of Mackay Memorial Hospital (16MMHIS074).

: The authors agree with the publication of this paper.

: The authors declare that there is no conflict of interest regarding the publication of this paper.

Document is current